Skip to main content
    L

    LeMaitre Vascular Inc (LMAT)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $76.10
    -0.91 (-1.18%)

    Market Cap: $1.76B

    Last updated: Nov 17, 2026 at 4:15 PM ET

    LeMaitre Vascular Inc (LMAT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    LeMaitre Vascular (LMAT) has a market cap of $1.76B and an enterprise value of $1.90B. Its trailing P/E of 27.7x is below its 10-year median of 41.2x.

    Total Valuation

    Enterprise value is 8.05% above the market cap, as debt exceeds cash.

    Market Cap$1.76B
    Enterprise Value$1.90B
    Latest price (Nov 17, 2026)$76.10

    Key Dates

    The next earnings report is expected on Feb 23, 2027, covering the quarter ending Dec 31, 2026. The next ex-dividend date is Nov 19, 2026.

    Next Earnings DateFeb 23, 2027 (expected)
    Last Earnings DateNov 4, 2026
    Next Ex-Dividend DateNov 19, 2026
    Next Payment DateDec 3, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 0.06% in the quarter ended Sep 30, 2026 and grew 0.87% a year over 2 years.

    Shares Outstanding22.87M
    Shares Change (YoY)+0.93%
    Shares Change (QoQ)+0.06%
    Share Count Growth (2Y CAGR)+0.87%

    Valuation Ratios

    Sales and book value multiples are 6.5x and 4.0x. Its year-end P/E ranged from 29.6x to 47.5x from 2016 to 2025.

    P/E Ratio27.7x
    Forward P/E26.6x
    P/S Ratio6.5x
    Forward P/S6.4x
    P/B Ratio4.0x
    P/TBV Ratio5.2x
    P/FCF Ratio26.0x
    P/OCF Ratio23.1x
    PEG Ratio2.6

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 22.1x EBITDA and 28.1x free cash flow.

    EV / Earnings30.1x
    EV / Sales7.1x
    EV / EBITDA22.1x
    EV / FCF28.1x

    Price Statistics

    The stock is down 13.33% over 52 weeks and trades 6.25% below its 50-day average.

    Beta (1Y)0.60
    52-Week Change-13.33%
    1-Month Change-7.54%
    3-Month Change-8.99%
    6-Month Change-24.48%
    5-Year Change+55.62%
    10-Year Change+286.53%
    Total Return (1Y)-12.25%
    Total Return (3Y CAGR)+13.66%
    Total Return (5Y CAGR)+9.08%
    Return vs SPY (1Y)-22.92%
    Max Drawdown (1Y)-34.81%
    Max Drawdown (3Y)-34.81%
    Sharpe Ratio (1Y)-0.26
    Correlation with SPY (1Y)0.17
    50-Day Average$81.17
    200-Day Average$93.86
    52-Week Range$76.60 to $117.37
    RSI (14 Days)38.3
    Average Volume (20 Days)286.99K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 14.60x current liabilities, and total debt is 0.39x shareholder equity.

    Current Ratio14.60x
    Quick Ratio12.54x
    Debt / Equity0.39x
    Debt / EBITDA1.99x
    Debt / FCF2.53x
    Interest Coverage14.15x

    Returns and Efficiency

    Return on invested capital is 9.47% over the last 12 months, against a 5-year average of 9.19%.

    Return on Equity (ROE)14.66%
    Return on Assets (ROA)9.65%
    Return on Invested Capital (ROIC)9.47%
    ROE (5Y Average)11.22%
    ROA (5Y Average)8.38%
    ROIC (5Y Average)9.19%
    Asset Turnover0.43x
    Inventory Turnover1.06x
    Receivables Turnover7.53x
    Cash Conversion Cycle374 days

    Taxes

    Income tax took 22.61% of pretax income over the last 12 months.

    Income Tax (TTM)$18.50M
    Effective Tax Rate22.61%

    Scores

    LMAT has an Altman Z-Score of 6.77, in the safe zone above 2.99, and a Piotroski F-Score of 7 of 9, in the average band of 3 to 7.

    Altman Z-Score6.77
    Altman Z ZoneSafe
    Piotroski F-Score7 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $269.36M over the last 12 months is up 11.83% from the 12 months before.

    Revenue$269.36M
    Revenue Growth (YoY)+11.83%
    Gross Profit$194.06M
    Operating Income$74.70M
    Pretax Income$81.83M
    Net Income$63.34M
    EBITDA$85.28M
    Reported EPS (TTM)$2.75

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 65.87% of the $656.03M in total assets.

    Cash and Equivalents$27.49M
    Total Debt$169.32M
    Net Debt$141.82M
    Net Debt Per Share$6.20
    Working Capital$470.89M
    Shareholder Equity$432.13M
    Book Value Per Share$18.89
    Tangible Book Value$336.89M
    Tangible Book Per Share$14.73
    Total Assets$656.03M
    Total Liabilities$223.90M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $9.21M of capital spending, operating cash flow left $67.00M of free cash flow.

    Operating Cash Flow$76.20M
    Capital Expenditures$9.21M
    Free Cash Flow$67.00M
    FCF Per Share$2.93
    Depreciation and Amortization$11.67M
    Dividends Paid$21.68M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 27.73%, against a 5-year average of 22.03%.

    Gross Margin72.04%
    Operating Margin27.73%
    Pretax Margin30.38%
    Net Margin23.51%
    EBITDA Margin31.66%
    FCF Margin24.87%
    Gross Margin (5Y Average)67.27%
    Operating Margin (5Y Average)22.03%
    Net Margin (5Y Average)17.78%

    Growth

    Revenue grew 15.58% a year over 3 years, and EPS 33.29% a year.

    Revenue Growth (3Y CAGR)+15.58%
    Revenue Growth (5Y CAGR)+14.05%
    EPS Growth (3Y CAGR)+33.29%
    EPS Growth (5Y CAGR)+18.82%
    FCF Growth (3Y CAGR)+49.81%
    FCF Growth (5Y CAGR)+18.54%
    Operating Income Growth (3Y CAGR)+36.28%
    Book Value Per Share Growth (2Y CAGR)+13.65%
    Tangible Book Per Share Growth (2Y CAGR)+23.03%

    Revenue and profit by year

    Dividends and Yields

    LMAT pays out 28.51% of earnings as dividends.

    Dividend Per Share (Annual)$1.00
    Dividend Yield1.31%
    Payment ScheduleQuarterly
    Dividend Growth (3Y CAGR)+16.96%
    Dividend Growth (5Y CAGR)+16.05%
    Payout Ratio28.51%
    FCF Payout Ratio32.36%
    Earnings Yield3.61%
    FCF Yield3.85%
    Buyback Yield0.10%
    Shareholder Yield1.34%

    Full dividend history

    Peer Position

    Against 9 similar companies, LMAT has the 4th highest P/E.

    P/E Ratio27.7x vs 20.7x median
    P/S Ratio6.5x vs 3.1x median
    ROIC9.47% vs 6.96% median
    Revenue Growth (Trailing 4 Quarters, YoY)+11.83% vs +8.20% median
    Dividend Yield1.31% vs 0.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 10.26% and EPS growth at 12.03% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+10.26%
    EPS Growth Forecast (2Y CAGR)+12.03%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About LMAT

    What is LMAT's market cap?

    LeMaitre Vascular has a market cap of $1.76B. Its enterprise value, which adds debt and subtracts cash, is $1.90B.

    What is LMAT's P/E ratio?

    LeMaitre Vascular has a trailing P/E ratio of 27.7x and a forward P/E of 26.6x.

    How many shares of LMAT are outstanding?

    LeMaitre Vascular has 22.87M shares outstanding. The count is up 0.93% from a year earlier.

    Does LMAT pay a dividend?

    Yes. LeMaitre Vascular pays $1.00 a share a year, a dividend yield of 1.31%.

    How much debt does LMAT have?

    LeMaitre Vascular has $169.32M of total debt and $27.49M of cash and equivalents, a net debt position of $141.82M.